STN 12.5 mg Pill - orange capsule/oblong
Pill with imprint STN 12.5 mg is Orange, Capsule/Oblong and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Novugen Pharma (USA) LLC.
Sunitinib is used in the treatment of Renal Cell Carcinoma; Pancreatic Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for STN 12.5 mg
Sunitinib Malate
- Imprint
- STN 12.5 mg
- Strength
- 12.5 mg
- Color
- Orange (orange opaque cap and orange opaque body)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novugen Pharma (USA) LLC
- National Drug Code (NDC)
- 82293-0014
Related images for "STN 12.5 mg"
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
